Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jenscare Scientific CoHKSE:09877 -2.09%33 PS Ratio is 19.74 as of Sep. 07, 2026, which is 43% below its 10-year median of 34.45. GuruFocus rates HKSE:09877 with a GF Score™ of 33/100. The stock has 4 warning signs investors should review. Among 803 Medical Devices & Instruments companies, Jenscare Scientific Co ranks worse than 91.66% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Jenscare Scientific Co's share price is HK$7.245.
Jenscare Scientific Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.37. Hence, Jenscare Scientific Co's PS Ratio for today is 19.74.
Good Sign:
Jenscare Scientific Co Ltd stock PS Ratio (=31.49) is close to 1-year low of 28.81.
The historical rank and industry rank for Jenscare Scientific Co's PS Ratio or its related term are showing as below:
HKSE:09877'
s PS Ratio Range Over the Past 10 Years
Min: 19.74 Med: 34.45 Max: 41.96
Current: 19.74
During the past 6 years, Jenscare Scientific Co's highest PS Ratio was 41.96. The lowest was 19.74. And the median was 34.45.
HKSE:09877's PS Ratio is ranked worse than 91.66% of 803
companies
in the Medical Devices & Instruments industry
Industry Median: 3.02
vs HKSE:09877: 19.74
Jenscare Scientific Co (HKSE:09877) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Jenscare Scientific Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jenscare Scientific Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Jenscare Scientific Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Jenscare Scientific Co's Share Price of today is HK$7.245.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jenscare Scientific Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.37.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Jenscare Scientific Co (HKSE:09877) has a PS Ratio of 19.74 as of Sep. 07, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Jenscare Scientific Co and its competitors. This is 43% below median its historical median of 34.45. Over the past decade, Jenscare Scientific Co's PS Ratio has ranged from 19.74 to 41.96. According to the industry distribution chart, Jenscare Scientific Co ranks #736 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 91.7%.
Is Jenscare Scientific Co's PS Ratio too high?
Jenscare Scientific Co's current PS Ratio of 19.74 is 43% below median its 10-year median of 34.45. Over the past 10 years, this metric has ranged from a low of 19.74 to a high of 41.96. The Medical Devices & Instruments industry median PS Ratio is 3.02. Jenscare Scientific Co's value of 19.74 is 553.6% above this industry median. Based on the distribution chart, Jenscare Scientific Co ranks #736 out of 803 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Jenscare Scientific Co has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Jenscare Scientific Co's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Jenscare Scientific Co ranks #736 out of 803 companies for PS Ratio. This places Jenscare Scientific Co in the lower half of its industry. The industry median PS Ratio is 3.02. Jenscare Scientific Co's value of 19.74 is 553.6% above this benchmark. Historically, Jenscare Scientific Co's own PS Ratio has ranged from 19.74 to 41.96 over the past decade. While the company's 10-year median is 34.45 vs. the industry median of 3.02, Jenscare Scientific Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 3.02, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jenscare Scientific Co's current PS Ratio of 19.74 is 553.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Jenscare Scientific Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 3.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jenscare Scientific Co's current PS Ratio is 19.74, which is 43% below median its own 10-year median of 34.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jenscare Scientific Co stock overvalued right now?
Jenscare Scientific Co (HKSE:09877) has a current PS Ratio of 19.74. The current PS Ratio is 19.74, which is 43% below median its 10-year median of 34.45 and 553.6% above the Medical Devices & Instruments industry median of 3.02. Jenscare Scientific Co's overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Jenscare Scientific Co (HKSE:09877), the current PS Ratio is 19.74 as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jenscare Scientific Co Ltd is engaged in the manufacturing, research, and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure. Geographically, the company generates the majority of its revenue from the Chinese mainland.
33GF Score
Get the complete analysis for HKSE:09877
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09877 has been successfully added to your 
